Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The objectives of the proposed project are:
1. To describe the patterns of mood stabilizer, antipsychotic, antidepressant, and
anxiolytic prescriptions during pregnancy over a period of 12 years (2002-2014) in women
aged 13 to 50 years who are diagnosed with bipolar disorder in Ontario.
2. To identify the factors associated with use of antipsychotics, antidepressants, and
antipsychotic-antidepressant polytherapy in pregnant women diagnosed with bipolar
disorder.
3. To assess the impact of antipsychotics, antidepressants, and
antipsychotic-antidepressant polytherapy on the risk of maternal, neonatal, and labour
and delivery outcomes in women with bipolar disorder.
4. To assess the impact of antipsychotics, antidepressants, antipsychotic-antidepressant
polytherapy on psychiatric readmission rates during the early postpartum period in women
with bipolar disorder.